{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-006793","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.778730+00:00","generated_at":"2026-05-30T14:33:27.080110+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ZEO ScientifiX launches monthly regenerative medicine educational series for physicians","bullets":["In-person events titled 'The Future of Biologic Medicine' focus on extracellular vesicles and autologous biologics.","First event held early September 2024; second on October 4; next forum scheduled November 8, 2024 in Davie, FL.","Events include expert-led discussions, lab tour at Nova Southeastern University, and regulatory overview.","Company completed Phase 1 trials for flagship product Zofin and is seeking Phase 2 trials for multiple indications.","Regenerative medicine market projected to reach ~$175B by 2032, 22.8% annual growth rate."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-006793","json":"https://secwatch.observer/filing/0001829126-24-006793.json","markdown":"https://secwatch.observer/filing/0001829126-24-006793.md","text":"https://secwatch.observer/filing/0001829126-24-006793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624006793/0001829126-24-006793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624006793/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:33:27.080110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}